These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23786804)

  • 61. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
    Defossez G; Quillet A; Ingrand P
    BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Beyond breast cancer: mammographic features and mortality risk in a population of healthy women.
    Murphy RA; Schairer C; Gierach GL; Byrne C; Sherman ME; Register TC; Ding J; Kritchevsky SB; Harris TB
    PLoS One; 2013; 8(10):e78722. PubMed ID: 24205300
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer.
    Sartor H; Zackrisson S; Elebro K; Hartman L; Borgquist S
    Cancer Causes Control; 2015 Jun; 26(6):931-9. PubMed ID: 25860114
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
    Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
    J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?
    Starikov A; Drotman M; Hentel K; Katzen J; Min RJ; Arleo EK
    Clin Imaging; 2016; 40(1):68-71. PubMed ID: 26549432
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The connecticut experiments second year: ultrasound in the screening of women with dense breasts.
    Weigert J; Steenbergen S
    Breast J; 2015; 21(2):175-80. PubMed ID: 25683369
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer.
    Yen AM; Wu WY; Tabar L; Duffy SW; Smith RA; Chen HH
    J Epidemiol; 2017 Mar; 27(3):98-106. PubMed ID: 28142043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
    Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
    Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Investigating the prognostic value of mammographic breast density and mammographic tumor appearance in women with invasive breast cancer: The Malmö Diet and cancer study.
    Sturesdotter L; Larsson AM; Zackrisson S; Sartor H
    Breast; 2023 Aug; 70():8-17. PubMed ID: 37285739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.
    Domingo L; Blanch J; Servitja S; Corominas JM; Murta-Nascimento C; Rueda A; Redondo M; Castells X; Sala M
    Eur J Cancer Prev; 2013 Jan; 22(1):21-8. PubMed ID: 22584215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mammographic breast density is associated with the development of contralateral breast cancer.
    Raghavendra A; Sinha AK; Le-Petross HT; Garg N; Hsu L; Patangan M; Bevers TB; Shen Y; Banu A; Tripathy D; Bedrosian I; Barcenas CH
    Cancer; 2017 Jun; 123(11):1935-1940. PubMed ID: 28135395
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
    Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
    AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in mammographic density and risk of breast cancer among a diverse cohort of women undergoing mammography screening.
    Gastounioti A; Cohen EA; Pantalone L; Ehsan S; Vasudevan S; Kurudi A; Conant EF; Chen J; Kontos D; McCarthy AM
    Breast Cancer Res Treat; 2023 Apr; 198(3):535-544. PubMed ID: 36800118
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mammographic changes resulting from benign breast surgery impair breast cancer detection at screening mammography.
    van Breest Smallenburg V; Duijm LE; Voogd AC; Jansen FH; Louwman MW
    Eur J Cancer; 2012 Sep; 48(14):2097-103. PubMed ID: 22513229
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening Program.
    Moshina N; Ursin G; Hoff SR; Akslen LA; Roman M; Sebuødegård S; Hofvind S
    Acta Radiol Open; 2015 Sep; 4(9):2058460115604340. PubMed ID: 26442439
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Impact of breast density on computer-aided detection (CAD) of breast cancer].
    Yang KY; Liu XJ; Zhai RY
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):360-3. PubMed ID: 22883457
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
    Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
    Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study.
    Krishnan K; Baglietto L; Apicella C; Stone J; Southey MC; English DR; Giles GG; Hopper JL
    Breast Cancer Res; 2016 Jun; 18(1):63. PubMed ID: 27316945
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radiological audit of interval breast cancers: Estimation of tumour growth rates.
    MacInnes EG; Duffy SW; Simpson JA; Wallis MG; Turnbull AE; Wilkinson LS; Satchithananda K; Rahim R; Dodwell D; Hogan BV; Blyuss O; Sharma N
    Breast; 2020 Jun; 51():114-119. PubMed ID: 32298962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.